Related Experiment Videos
The continuing challenge of lower respiratory tract infections
1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA. rmoeller@caregroup.harvard.edu
Abstract:
Lower respiratory tract infections have been a major cause of morbidity and mortality among humans since the dawn of history. The initial hope that the era of antibiotics would remove this scourge has been replaced by the more realistic view that although antimicrobial agents represent a major therapeutic advance, they have not yet solved all of the problems of lower respiratory tract infections. The pneumococcus, for example, causes mortality in a certain number of patients despite antimicrobial therapy. An even greater challenge is being imposed by the emergence of antimicrobial resistance among important bacterial pathogens, especially Streptococcus pneumoniae.
Insights
Lower respiratory tract infections remain a significant health threat, with antibiotics not fully resolving issues like pneumococcal mortality. Antimicrobial resistance, particularly in Streptococcus pneumoniae, presents a growing challenge.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Lower respiratory tract infections (LRTIs) have historically caused substantial human morbidity and mortality.
- While antibiotics represent a therapeutic advance, they have not eradicated the threat of LRTIs.
- The emergence of antimicrobial resistance poses a significant and growing challenge to treating bacterial infections.
Purpose of the Study:
- To highlight the persistent impact of LRTIs despite antibiotic availability.
- To underscore the challenge posed by antimicrobial resistance in bacterial pathogens.
- To emphasize the specific threat of Streptococcus pneumoniae resistance.
Main Methods:
- This abstract does not detail specific methods.
- The content is a narrative review of the historical and current challenges of LRTIs.
- Focuses on the clinical and epidemiological aspects of bacterial respiratory infections.
Main Results:
- Antimicrobial agents have not completely solved problems associated with LRTIs.
- Certain pathogens, like Streptococcus pneumoniae (pneumococcus), continue to cause mortality even with antimicrobial therapy.
- Antimicrobial resistance is an increasing problem, especially with key pathogens such as Streptococcus pneumoniae.
Conclusions:
- LRTIs remain a critical global health concern.
- The effectiveness of antibiotics is threatened by the rise of antimicrobial resistance.
- Continued vigilance and research are necessary to combat resistant bacterial infections.